Inhibikase Therapeutics
4 clinical trials · Sponsor
◉ Watch Inhibikase Therapeutics
| Record | Firm | Date |
|---|---|---|
| Open-Label Study of IKT-001 in Pulmonary Arterial Hypertension (PAH) (NCT07632898) | Inhibikase Therapeutics | 2026-10-23 |
| An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH) (NCT07365332) | Inhibikase Therapeutics | 2026-04-23 |
| A Phase 2 Study of IkT-001Pro in Pulmonary Arterial Hypertension (PAH) (NCT06643143) | Inhibikase Therapeutics | 2025-06-30 |
| A Dose Calibration Study Comparing IkT-001Pro to Imatinib Mesylate 400mg (NCT05623774) | Inhibikase Therapeutics | 2022-12-16 |
Track Inhibikase Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.